help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BISGAARD, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BISGAARD, H.

Am. J. Respir. Crit. Care Med., Volume 157, Number 2, February 1998, 518-521

Automatic Actuation of a Dry Powder Inhaler into a Nonelectrostatic Spacer

HANS BISGAARD

Pulmonary Service, Department of Pediatrics, Rigshospitalet, National University Hospital, Copenhagen, Denmark

This article describes a new "automatic spacer" device, which has been developed to improve the delivery of inhaled medication to young children. In the device, a dry powder inhaler (DPI) is mechanically actuated into a nonelectrostatic spacer, producing an aerosol cloud of fine drug particles (aerodynamic diameter, < 4.7 µm) with a long half-life. The new device combines the principal advantages of the conventional spacer and the DPI. It has the potential to provide a high ratio between lung dose and pharyngeal dose, without need for coordination or forced inhalation, and it avoids exposure of the patient to the additives and propellants used in pressurized metered dose inhalers. Studies with the protototype device show a high yield of fine drug particles in the aerosol (mass median aerodynamic diameter, 2.8 µm), a high repeatability of drug delivery owing to the mechanical nature of the actuation (relative standard deviation, 12%), and a prolonged residence time of the fine particle aerosol (half-life of the fallout of the fine particles, 82 s). These features should prove advantageous in the treatment of young children with inhaled medication.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
K. G. NIELSEN and H. BISGAARD
Bronchodilation and Bronchoprotection in Asthmatic Preschool Children from Formoterol Administered by Mechanically Actuated Dry-powder Inhaler and Spacer
Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 256 - 259.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
Inhalation devices and propellants
Can. Med. Assoc. J., November 1, 1999; 161(90111): s44 - 50.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society